Treating the hype: supports and treatment responses for people impacted by methamphetamine use
Australian Institute of Health and Welfare data list methamphetamine use second only to alcohol as the most common drug of concern in clients attending AOD services in Australia. Whilst overall rates of methamphetamine use in Australia have remained stable in recent years, people who use methamphetamine are reporting higher rates of regular and dependent use, leading to complex physical, mental health and social problems. The role of treatment and other interventions is crucial in addressing these, with residential rehabilitation, withdrawal management and counselling making up the current treatment options. The evidence base for stimulant-specific interventions and treatment is modest, but building, recognising the need for effective support that acknowledges the frequent experience of discrimination with this substance. This presentation will discuss where the A)D sector goes from here…
Brought to you in partnership with Insight and NCCRED (National Centre for Clinical Research on Emerging Drugs).
NADA recently held webinar to train members on how to use, analyse and maximise the new NADAbase dashboards. Did you miss out? Watch the video recording below.
Engaging consumers: Tricky or transformational?
In this video recording, we delve into the role of language, consumers and research and hear consumers experiences of engagement. Watch to acquire insights into the significance of lived experience in relation to consumer participation, gain an understanding of the role which language can play regarding access and equity and increase your awareness about the developing role of consumers in research.
This webinar was brought to you in partnership with the Australasian Professional Society on Alcohol and Other Drugs and the Network of Alcohol and other Drugs Agencies.